For the quarter ended September 2025, Elanco Animal Health Incorporated (ELAN Quick QuoteELAN - Free Report) reported revenue of $1.14 billion, up 10.4% over the same period last year. EPS came in at $0.19, compared to $0.13 in the year-ago quarter.

The reported revenue represents a surprise of +4.28% over the Zacks Consensus Estimate of $1.09 billion. With the consensus EPS estimate being $0.13, the EPS surprise was +46.15%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Elanco Animal Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenue- Total Pet Health: $533 million versus $535.97 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +9.7% change.
• Revenue- Total Contract Manufacturing: $11 million versus the four-analyst average estimate of $13.09 million. The reported number represents a year-over-year change of -21.4%.
• Revenue- Total Farm Animal: $593 million versus the four-analyst average estimate of $542.9 million. The reported number represents a year-over-year change of +11.9%.

View all Key Company Metrics for Elanco Animal Health here>>>

Shares of Elanco Animal Health have returned +10% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.